Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Tokyo Big Sight

Nov 10, 2019 9:30 AM - Nov 12, 2019 5:40 PM

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

16th DIA Japan Annual Meeting 2019

Delivering Rational Medicine for All People in the Globe

[S38] Regenerative Medical Products - Learn from the Latest Approved Products -

Session Chair(s)

Daisaku  Sato, PhD, MPharm, RPh

Daisaku Sato, PhD, MPharm, RPh

Director, Compliance & Narcotics Division

Ministry of Health, Labour and Welfare, Japan

Two new regenerative medical products were approved in 2018, after 3 years since last approval. Many academias and the industries are working on researches and development toward the commercialization of regenerative medical products to cure the intractable diseases. In this session, we will have speakers from the companies that had recently approved products and from PMDA. The issues to address which occurred during the development and/or after launch will be presented, in addition, reviewer’s points of view will be explained. Attendees will expect to learn the cases from the lectures and panel discussion.


Yoshihiro  Yoshikawa

Strategy, Issues, and Challenges - the Case of Stemirac

Yoshihiro Yoshikawa

Nipro Corporation, Japan

General Manager, Research & Development Center for Regenerative Medicine

Yayoi  Kitawaki, MS

Development Strategy and Challenges for Practical Application in Kymriah

Yayoi Kitawaki, MS

Novartis Pharma K.K., Japan

Head, RA Immunology Japan, Global Development Division

Yoshiaki  Maruyama, PhD

Evaluation of Regenerative Medical Products - General Considerations -

Yoshiaki Maruyama, PhD

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Review Director, Office of Cellular and Tissue-based Products

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.